Small molecules for perturbing iron homeostasis in bacterial biofilms

扰乱细菌生物膜中铁稳态的小分子

基本信息

  • 批准号:
    10573309
  • 负责人:
  • 金额:
    $ 72.86万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-02-15 至 2027-01-31
  • 项目状态:
    未结题

项目摘要

ABSTRACT Chronic wound care is especially complicated by the formation of bacterial biofilms, commonly by Pseudomonas aeruginosa, Acinetobacter baumannii and Staphylococcus aureus. Biofilms are recalcitrant to antibiotic therapy, which is an important reason why chronic wound infections are so difficult to eradicate. There is a significant need to discover new strategies to combat biofilms. Bacterial iron homeostasis is a suitable novel target for developing anti-infectives because the host makes essential iron scarce to invading pathogens. Bacteria have evolved mechanisms to “steal” iron from their host, but these depend on well-regulated iron homeostasis. To disrupt bacterial iron homeostasis, we are targeting the iron storage protein BfrB and its physiological partner protein, Bfd, which are unique to bacteria. Our work has shown that BfrB regulates cytosolic iron concentrations by (a) oxidizing Fe2+ and storing up to ~3,000 Fe3+ ions in its internal cavity, and (b) forming a complex with Bfd to reduce Fe3+ in the internal cavity of BfrB and release Fe2+ to the cytosol for its incorporation in metabolism. Blocking the BfrB-Bfd complex in P. aeruginosa cells by deletion of the bfd gene perturbs iron homeostasis by triggering an irreversible accumulation of Fe3+ in BfrB and simultaneous cytosolic iron depletion, which leads to impaired biofilm maintenance and biofilm cell death. Our work also led to the discovery of proof-of-concept inhibitors of the BfrB-Bfd complex, which bind BfrB at the Bfd binding site, inhibit iron mobilization, and elicit biofilm cell death. The objectives of this application are to improve the proof-of-concept molecules into lead molecules, evaluate their antibacterial and antibiofilm effectiveness, and evaluate their potential drug suitability. Our interdisciplinary team includes expertise in chemical and structural biology of bacterial iron homeostasis (Rivera), organic synthesis and reaction mechanisms (Bunce), pharmaceutical industry research and development of anti-infectives (Reitz), X-ray crystallography in drug discovery (Lovell), microbial genetics (Chandler), and animal model of infection (Morici). The specific aims are: 1) Evolve proof-of-concept analogs into potent inhibitors of the BfrB-Bfd complex. This work will follow a systematic, iterative strategy of medicinal chemistry synthesis optimization that relies on crystal structures of inhibitor bound BfrB to design each new generation of inhibitors. 2) Asses the antibacterial effectiveness of inhibitors of the BfrB-Bfd complex and evaluate their potential drug suitability.
抽象的 细菌生物膜(通常是假单胞菌)的形成使慢性伤口护理变得尤其复杂 铜绿假单胞菌、鲍曼不动杆菌和金黄色葡萄球菌。生物膜对抗生素治疗有抵抗力, 这是慢性伤口感染难以根除的重要原因。有一个显着的 需要发现对抗生物膜的新策略。细菌铁稳态是一个合适的新靶点 开发抗感染药物是因为宿主使入侵的病原体缺乏必需的铁。细菌有 进化出从宿主“窃取”铁的机制,但这取决于良好调节的铁稳态。到 破坏细菌铁稳态,我们的目标是铁储存蛋白 BfrB 及其生理伙伴 蛋白质,Bfd,是细菌特有的。我们的工作表明 BfrB 调节胞质铁浓度 通过 (a) 氧化 Fe2+ 并在其内腔中储存多达约 3,000 个 Fe3+ 离子,以及 (b) 与 Bfd 形成复合物 还原 BfrB 内腔中的 Fe3+ 并将 Fe2+ 释放到细胞质中以参与代谢。 通过删除 bfd 基因来阻断铜绿假单胞菌细胞中的 BfrB-Bfd 复合物,从而扰乱铁稳态 触发 BfrB 中 Fe3+ 不可逆积累,同时胞质铁耗尽,从而导致 生物膜维持受损和生物膜细胞死亡。我们的工作还导致了概念验证的发现 BfrB-Bfd 复合物的抑制剂,在 Bfd 结合位点结合 BfrB,抑制铁动员,并引发 生物膜细胞死亡。该应用的目标是将概念验证分子改进为领先的 分子,评估其抗菌和抗生物膜有效性,并评估其潜在的药物适用性。 我们的跨学科团队包括细菌铁稳态的化学和结构生物学方面的专业知识 (Rivera)、有机合成与反应机理(Bunce)、制药工业研究与 抗感染药物的开发 (Reitz)、药物发现中的 X 射线晶体学 (Lovell)、微生物遗传学 (钱德勒)和感染动物模型(莫里奇)。具体目标是:1)发展概念验证类似物 转化为 BfrB-Bfd 复合物的有效抑制剂。这项工作将遵循系统的、迭代的医学策略 化学合成优化依赖于抑制剂结合 BfrB 的晶体结构来设计每个新的 抑制剂的产生。 2) 评估 BfrB-Bfd 复合物抑制剂的抗菌效果 评估其潜在的药物适用性。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Mario Rivera其他文献

Mario Rivera的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Mario Rivera', 18)}}的其他基金

Chemical tools for perturbing iron homeostasis in P. aeruginosa
扰乱铜绿假单胞菌铁稳态的化学工具
  • 批准号:
    9158507
  • 财政年份:
    2016
  • 资助金额:
    $ 72.86万
  • 项目类别:
Chemical tools for perturbing iron homeostasis in P. aeruginosa
扰乱铜绿假单胞菌铁稳态的化学工具
  • 批准号:
    9674978
  • 财政年份:
    2016
  • 资助金额:
    $ 72.86万
  • 项目类别:
DYNAMICS & INTERPROTEIN INTERACTIONS IN RELEASE OF IRON IN BACTERIOFERRITIN
动力学
  • 批准号:
    8359665
  • 财政年份:
    2011
  • 资助金额:
    $ 72.86万
  • 项目类别:
MECHANISM OF HEME CAPTURE BY THE HEMOPHORE SECRETED BY PSEUDOMONAS AERUGINOSA
铜绿假单胞菌分泌的血红素捕获血红素的机制
  • 批准号:
    7959522
  • 财政年份:
    2009
  • 资助金额:
    $ 72.86万
  • 项目类别:
CYTOCHROME B5--A CASE STUDY IN MOLECULAR RECOGNITION
细胞色素 B5——分子识别案例研究
  • 批准号:
    2188376
  • 财政年份:
    1995
  • 资助金额:
    $ 72.86万
  • 项目类别:
CYTOCHROME B5--A CASE STUDY IN MOLECULAR RECOGNITION
细胞色素 B5——分子识别案例研究
  • 批准号:
    2685028
  • 财政年份:
    1995
  • 资助金额:
    $ 72.86万
  • 项目类别:
Structure, Function and Dynamics of Heme Degrading Enzymes
血红素降解酶的结构、功能和动力学
  • 批准号:
    7199450
  • 财政年份:
    1995
  • 资助金额:
    $ 72.86万
  • 项目类别:
Structure, Function and Dynamics of Heme Degrading Enzymes
血红素降解酶的结构、功能和动力学
  • 批准号:
    7286752
  • 财政年份:
    1995
  • 资助金额:
    $ 72.86万
  • 项目类别:
Cytochrome b5--A Case Study in Molecular Recognition
细胞色素b5——分子识别案例研究
  • 批准号:
    6606890
  • 财政年份:
    1995
  • 资助金额:
    $ 72.86万
  • 项目类别:
CYTOCHROME B5--A CASE STUDY IN MOLECULAR RECOGNITION
细胞色素 B5——分子识别案例研究
  • 批准号:
    2392193
  • 财政年份:
    1995
  • 资助金额:
    $ 72.86万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 72.86万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 72.86万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 72.86万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 72.86万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 72.86万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 72.86万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 72.86万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 72.86万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 72.86万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 72.86万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了